Home > Insider Trading > Filing (0001179110-11-015909)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1145460	Alere Inc.	ALR	In Vitro & In Vivo Diagnostic Substances (2835)	043565120

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1033438	David Scott	51 Sawyer Road, Suite 200 Waltham MA 02453	Chief Technical Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-11-16	199,691	$15.47	639,906	No	4	M	Direct
Common Stock	Disposition	2011-11-16	164,237	$26.02	475,669	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Footnotes

The transactions reported on this Form were made pursuant to a written 10b5-1 trading plan adopted in accordance with SEC Rule 10b5-1. Represents sell to cover exercise of expiring stock options.
Represents the weighted average purchase price. Securities were sold through approximately 1,015 separate block trades executed on the Transaction Date at an average price of $26.022. The reporting person hereby undertakes to provide upon request to the SEC, the issuer or any stockholder of the issuer the full information regarding the number of shares and prices at which the transaction was effected.
The acquisition price per share of this security, $15.47, was incorrectly reported in the original Form 4 as $14.57.
These securities were incorrectly reported as Securities Acquired (A) in the original Form 4, although the amount of Securities Beneficially Owned Following Reported Transaction(s) was correctly reported.